News

Researchers have found that memory B cells need the help of other memory cells to effectively defend the body against chronic viruses such as HIV, an important finding for vaccine design.

Detecting the activity of CRISPR gene editing tools in organisms with the naked eye and an ultraviolet flashlight is now possible using technology developed at the Department of Energy’s Oak Ridge National Laboratory.

A team led by Caltech researchers has developed a gene-delivery system that can specifically target brain cells while avoiding the liver.

MIT chemical engineers have demonstrated that they can protect bacteria used to develop biotherapeutics with a coating that helps them to survive the manufacturing process.

A molecule has been refined and has the potential to be developed into a drug to treat Parkinson’s disease.

Researchers have identified crucial ways that immune system cells congregate and communicate with each other to identify and eradicate tumor cells.

Researchers have investigated where and how mRNA is delivered inside the cell. They found that mRNA uses an unexpected entry door.

An experimental HIV vaccine based on mRNA – the same platform technology used in two highly effective COVID-19 vaccines – shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The US Food and Drug Administration (FDA) has issued an emergency use authorization for AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab and administered together) to COVID-19 in certain adults and pediatric individuals.

A new pre-print study shared by Professor Alex Sigal’s laboratory at the Africa Health Research Institute is the first scientific data to be published on Omicron. Let's break down the findings.